as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
4.92%
Downside
1.64%
Upside
52 Week's Low
52 Week's High
22.17%
Downside
47.54%
Upside
Check Lucid Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$161.3M
EPS (TTM)
-0.4333
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.92
Industry PE ratio
-1.6902868852459016
PEG Ratio
0EBITDA
-47.1M
Revenue (TTM)
4.4M
Profit Margin
0.00%
Return On Equity TTM
-331.24%
Track how Lucid Diagnostics Inc. P/E has moved over time to understand its valuation trends.
Lucid Diagnostics Inc. in the last 5 years
Lowest (-4.47x)
December 31, 2021
Industry (-1.69x)
February 7, 2026
Today (-0.92x)
February 7, 2026
Highest (-0.69x)
June 30, 2024
Today’s Price to Earnings Ratio: -0.92x
Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $161.3M | NA | -0.92 | 0.00% | |
| BUY | $138.7B | 95.76% | 50.03 | 14.43% | |
| BUY | $136.5B | 50.05% | 46.97 | 12.07% | |
| BUY | $129.1B | -13.09% | 27.28 | 13.71% | |
| BUY | $189.3B | -10.64% | 29.24 | 14.72% |
The Lucid Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lucid Diagnostics Inc. investment value today
Current value as on today
₹1,17,328
Returns
₹17,328
(+17.33%)
Returns from Lucid Diagnostics Inc. Stock
₹14,019 (+14.02%)
Dollar Returns*
₹3,309 (+3.31%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lucid Diagnostics Inc.. Average target price of $3.79
Get share price movements and forecasts by analysts on Lucid Diagnostics Inc..
What analysts predicted
67.81%UPSIDE
Target Price
$3.79
Current Price
$1.22
Analyzed by
12 Analysts
Target
$3.79
Lucid Diagnostics Inc. target price $3.79, a slight upside of 67.81% compared to current price of $1.22. According to 12 analysts rating.
Search interest for Lucid Diagnostics Inc. Stock has increased by 184% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:184% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, LUCD stock has moved up by 24.4%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 828.0K → 1.21B (in $), with an average increase of 64.4% per quarter
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 18.8% return, outperforming this stock by 25.0%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 14.3% return, outperforming this stock by 0.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -4.43M → -10.39B (in $), with an average decrease of 234119.4% per quarter
| Organisation | Lucid Diagnostics Inc. |
| Headquarters | 360 Madison Avenue, New York, NY, United States, 10017 |
| Industry | Healthcare |
| CEO | Dr. Lishan Aklog M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Lishan Aklog M.D. | Chairman & CEO |
Mr. Dennis M. McGrath CPA | Chief Financial Officer |
Mr. Michael Adam Gordon | General Counsel & Secretary |
Dr. Joseph Willis M.D. | Co-founder & Strategic Advisor |
Mr. Shaun M. O'Neill M.B.A. | President & COO |
Dr. Sanford D. Markowitz M.D., Ph.D. | Co-Founder & Strategic Advisor |
Dr. Amitabh Chak M.D. | Co-Founder & Strategic Advisor |
Helen Moinova Ph.D. | Co-Founder & Strategic Advisor |
Dr. Brian J. deGuzman M.D. | Chief Technology & Compliance Officer |
Dr. Suman M. Verma M.D., Ph.D. | Chief Scientific Officer |
Lucid Diagnostics Inc. share price today is $1.22 as on at the close of the market. Lucid Diagnostics Inc. share today touched a day high of $1.24 and a low of $1.16.
Lucid Diagnostics Inc. share touched a 52 week high of $1.8 on and a 52 week low of $0.95 on . Lucid Diagnostics Inc. stock price today i.e. is closed at $1.22,which is 32.22% down from its 52 week high and 28.49% up from its 52 week low.
Lucid Diagnostics Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Lucid Diagnostics Inc. (LUCD) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Lucid Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lucid Diagnostics Inc. share’s latest price of $1.22 as on February 7, 2026 at 2:29 am IST, you will get 8.1967 shares of Lucid Diagnostics Inc.. Learn more about
fractional shares .